Price Alert

Protalix BioTherapeutics ... (PLX)

AMEX: PLX · Real-Time Price · USD

1.48

-0.04 (-2.63%)

At close: Aug 15, 2025, 3:59 PM

1.50

1.35%

After-hours: Aug 15, 2025, 05:59 PM EDT

Protalix BioTherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	19.46M	19.76M	27.41M	23.4M	27.21M	23.63M	20.41M	48.18M	33.04M	17.11M	10.72M	12.49M	16.89M	38.98M	10.64M	33.88M	19.83M
Short-Term Investments	15.29M	15.07M	n/a	21.63M	21.28M	20.93M	20.57M	n/a	n/a	5.07M	10.09M	16.08M	16.03M	38.98M	38.02M	43.06M	50.6M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	459K	462K	561K	535K	531K	528K	1.26M	1.27M	1.25M	1.27M	1.42M	1.4M	2.05M	2.08M	1.95M	1.88M	1.78M
Receivables	4.67M	2.91M	2.19M	10.13M	3.76M	5.27M	8.94M	4.05M	1.3M	4.59M	8.65M	2.02M	5.91M	3.44M	5.56M	2.33M	4.6M
Inventory	19.51M	21.24M	17.2M	20.72M	22.35M	19.05M	21.58M	19.64M	20.3M	16.8M	14.56M	16.51M	16.59M	17.95M	14.73M	13.64M	13.91M
Other Current Assets	1.59M	596K	1.05M	1.49M	812K	611K	1.13M	1.71M	758K	536K	1.74M	2.6M	1.12M	380K	2.27M	3.01M	1.75M
Total Current Assets	60.51M	60.08M	47.85M	77.37M	75.4M	69.93M	72.62M	73.58M	55.4M	44.88M	45.76M	49.7M	56.54M	61.67M	71.22M	95.92M	90.7M
Property-Plant & Equipment	9.95M	10.02M	10.29M	10.34M	10.66M	10.88M	10.6M	10.44M	9.91M	9.64M	9.53M	9.54M	9.8M	9.92M	10.31M	10.4M	10.32M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	13.38M	13.34M	13.71M	14.17M	14.42M	14.5M	14.95M	14.84M	11.16M	10.91M	10.95M	10.94M	11.85M	12M	12.26M	12.28M	12.09M
Total Assets	73.89M	73.42M	61.56M	91.54M	89.83M	84.43M	87.57M	88.42M	66.56M	55.79M	56.71M	60.64M	68.39M	73.67M	83.48M	108.2M	102.79M
Account Payables	4.12M	4.53M	3.13M	4.06M	3.15M	4.32M	3.11M	3.3M	5.11M	5.86M	5.64M	6.99M	7.87M	6.99M	8.44M	6.13M	6.38M
Deferred Revenue	2M	n/a	n/a	12.7M	11.04M	2.88M	-3.11M	n/a	11.79M	13.18M	14.79M	10.22M	11.8M	8.55M	15.16M	18.11M	2.56M
Short-Term Debt	n/a	n/a	n/a	21.87M	20.42M	21.66M	21.5M	1.26M	1.15M	n/a	1M	1.08M	1.24M	n/a	4.47M	57.59M	56.76M
Other Current Liabilities	1.88M	1.81M	15.97M	4.6M	1.7M	16.7M	6.56M	17.29M	12.32M	11.05M	11.87M	11.58M	13.17M	14.87M	13.46M	13.19M	13.78M
Total Current Liabilities	24.32M	25.62M	24.22M	57.97M	54.83M	45.53M	43.36M	23.11M	31.52M	32.43M	34.3M	30.96M	35.33M	33.18M	42.76M	96.25M	80.86M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	20.13M	28.27M	28.19M	28.11M	28.03M	27.96M	27.89M	27.82M	n/a	n/a
Other Long-Term Liabilities	551K	559K	730K	705K	712K	714K	1.46M	1.6M	1.62M	1.64M	1.78M	1.75M	2.5M	2.47M	2.35M	2.34M	2.25M
Total Long-Term Liabilities	4.36M	4.58M	4.91M	4.99M	5.21M	5.33M	5.96M	26.31M	34.04M	34M	33.92M	39.57M	40.55M	46.52M	40.51M	8.12M	7.43M
Total Liabilities	28.68M	30.21M	29.13M	62.96M	60.04M	50.87M	49.32M	49.42M	65.55M	66.43M	68.22M	70.53M	75.88M	79.7M	83.27M	104.36M	88.29M
Total Debt	5.24M	5.53M	5.68M	26.15M	26.37M	26.28M	26.01M	25.97M	33.57M	33.47M	33.14M	33.01M	33.4M	33.47M	36.73M	62.1M	61.08M
Common Stock	78K	76K	n/a	73K	73K	73K	73K	72K	62K	54K	50K	49K	46K	46K	46K	46K	46K
Retained Earnings	-382.01M	-378.39M	-384.89M	-388.12M	-385.92M	-381.55M	-375.5M	-373.65M	-392.99M	-389.86M	-386.12M	-382.55M	-377.22M	-374.93M	-368.27M	-364.07M	-352.83M
Comprehensive Income	n/a	n/a	n/a	n/a	0.00	-0.00	n/a	n/a	0.00	n/a	-0.00	n/a	0.00	0.00	-0.00	n/a	n/a
Shareholders Equity	45.21M	43.21M	32.44M	28.58M	29.79M	33.57M	38.25M	39M	1.01M	-10.64M	-11.51M	-9.89M	-7.49M	-6.04M	213K	3.84M	14.5M
Total Investments	15.29M	15.07M	n/a	21.63M	21.28M	20.93M	20.57M	n/a	n/a	5.07M	10.09M	16.08M	16.03M	38.98M	38.02M	43.06M	50.6M